首页 | 本学科首页   官方微博 | 高级检索  
     


Management of malignant pleural mesothelioma
Authors:Anna K NOWAK   Sean BYDDER
Affiliation:School of Medicine and Pharmacology, University of Western Australia and;Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
Abstract:Malignant mesothelioma is a highly fatal malignancy that may become more prevalent in the Asia–Pacific region over the next decades. We review clinical aspects of this disease, including presentation, diagnosis, staging and management. A small proportion of patients will be suitable for aggressive trimodality therapy (extra‐pleural pneumonectomy, chemotherapy and radiotherapy) with the aim of cure or achieving prolonged palliation. However, most patients will present with advanced disease and so are only suitable for palliation. We review palliative therapy with an emphasis on the practical aspects of chemotherapy as well as palliative procedures such as pleurodesis. The future direction of clinical research in mesothelioma is discussed.
Keywords:malignant mesothelioma    antineoplastic therapy    pemetrexed    cisplatin    radiotherapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号